Charter Renewal for the Advisory Committee on Heritable Disorders in Newborns and Children, 89649-89650 [2024-26198]

Download as PDF Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices administering FDA regulations pertaining to the manufacturing/ processing, packing, or holding of food for consumption in the United States. The Produce Regulatory Program Standards (PRPS) are the result of external collaboration and coordination with the Association of Food and Drug Officials (AFDO), the National Association of State Departments of Agriculture (NASDA), and state produce regulatory programs. FDA, NASDA, AFDO, and states worked collaboratively to develop the content of the PRPS. A copy of the standards and accompanying worksheets and forms is available in the Federal Register docket for this notice. We recommend that State and Territorial produce safety regulatory programs use these program standards as the framework to design and manage their produce safety regulatory programs. The states that assisted in the development of PRPS were representative of the 43 State and Territorial programs regulatory programs enrolled currently conducting produce safety inspections via funding from a cooperative agreement grant, ‘‘The FDA’s Cooperative Agreement Program for States and Territories to Implement a National Produce Safety Program, PAR–21–174,’’ (this program also includes 4 programs which do not conduct inspections). For more information on this cooperative agreement, we invite you to visit our website at: https://www.fda.gov/federalstate-local-tribal-and-territorialofficials/grants-and-cooperativeagreements/fda-state-produce-safetyimplementation-cooperative-agreementprogram. The PRPS identifies and includes resource and training material for the following standards: regulatory foundations; training; inspection; product-specific illnesses, outbreaks and hazard response; compliance and enforcement; industry and community relations; program assessments; and product sampling and testing. We recommend using the worksheets and forms contained in the standards, however, alternate forms that are equivalent may be used. The educational worksheets and resource materials include recordkeeping and reporting activities that help FDA verify participation and successful completion 89649 of the respective requirements. In the first year of enrollment, information is used to conduct a baseline selfassessment to determine whether the materials meet the elements of each standard. In subsequent years, we use the information to conduct a comprehensive review and evaluate program effectiveness and participation. We modify the program standards based on the ongoing assessments as well as comments and informal feedback obtained from participants. Description of Respondents: Respondents are State Departments of Agriculture or Health regulatory officials who enroll in the PRPS (State or Territorial governments). Currently we estimate 43 respondents to the information collection based on expected participation. In the Federal Register of June 28, 2024 (89 FR 54009), FDA published a 60-day notice requesting public comment on the proposed collection of information. One comment was received that did not pertain to the information collection. FDA estimates the burden of this collection of information as follows: TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1 Respondent Number of recordkeepers Number of records per recordkeeper Total annual records Average burden per recordkeeping Total hours State or Territorial Governments; Maintenance of data records consistent with the PRPS ................................... 48 11 528 85.36 45,072 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Dated: October 30, 2024. Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs. [FR Doc. 2024–26209 Filed 11–12–24; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. lotter on DSK11XQN23PROD with NOTICES1 AGENCY: In accordance with the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that the Advisory Committee on Heritable VerDate Sep<11>2014 17:40 Nov 12, 2024 Jkt 265001 ACHDNC provides advice and recommendations to the Secretary of Health and Human Services (Secretary) on the development of newborn screening activities, technologies, policies, guidelines, and programs for effectively reducing morbidity and mortality in newborns and children having, or at risk for, heritable disorders. ACHDNC reviews and reports regularly on newborn and childhood screening practices, recommends improvements in the national newborn and childhood screening programs, and fulfills requirements stated in the authorizing SUPPLEMENTARY INFORMATION: Charter Renewal for the Advisory Committee on Heritable Disorders in Newborns and Children SUMMARY: Disorders in Newborns and Children (ACHDNC) charter has been renewed. DATES: The effective date of charter renewal is November 10, 2024. FOR FURTHER INFORMATION CONTACT: Leticia Manning, Maternal and Child Health Bureau, HRSA, 5600 Fishers Lane, 18N38A, Rockville, Maryland 20857; 301–443–8335; or lmanning@ hrsa.gov. PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 legislation. In addition, ACHDNC’s recommendations regarding inclusion of conditions for screening on the Recommended Uniform Screening Panel, following adoption by the Secretary, are evidence-informed preventive health services provided for in the comprehensive guidelines supported by HRSA pursuant to section 2713 of the Public Health Service Act (42 U.S.C. 300gg–13). Under this provision, non-grandfathered group health plans and health insurance issuers offering non-grandfathered group or individual health insurance are required to provide insurance coverage without cost-sharing (a co-payment, coinsurance, or deductible) for preventive services for plan years (i.e., policy years) beginning on or after the date that is 1 year from the Secretary’s adoption of the condition for screening. The charter renewal for the ACHDNC was approved on October 29, 2024. The filing date is November 10, 2024. Renewal of the ACHDNC charter E:\FR\FM\13NON1.SGM 13NON1 89650 Federal Register / Vol. 89, No. 219 / Wednesday, November 13, 2024 / Notices authorizes the committee to operate until November 10, 2026 A copy of the ACHDNC charter is available on the ACHDNC website at https://www.hrsa.gov/advisorycommittees/heritable-disorders/ index.html. A copy of the charter also can be obtained by accessing the FACA database that is maintained by the Committee Management Secretariat under the General Services Administration. The website address for the FACA database is https:// www.facadatabase.gov/. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2024–26198 Filed 11–12–24; 8:45 am] BILLING CODE 4165–15–P Dated: November 7, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Notice of Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Science Advisory Board for Biosecurity. The meeting will be held as a virtual meeting and will be open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/). Name of Committee: National Science Advisory Board for Biosecurity. Date: November 21, 2024. Time: 1:00 p.m. to 2:00 p.m. Agenda: The National Science Advisory Board for Biosecurity meeting will include a review of a new charge to the committee and discussion of next steps for the committee. Address: National Institutes of Health, 6705 Rockledge Drive, Suite 630, Bethesda, MD 20892. Meeting Format: Virtual Meeting. Meeting Access: https://osp.od.nih.gov/ policies/national-science-advisory-board-forbiosecurity-nsabb#tab3/. Contact Person: Cari Young, ScM, Office of Science Policy, Office of the Director, National Institutes of Health, 6705 Rockledge Drive, Suite 630, Bethesda, MD 20892, 301– 496–9838, SciencePolicy@od.nih.gov. This notice is being published less than 15 days from the meeting date due to exceptional circumstances which did not allow sufficient time to submit the notice within the typical lead time VerDate Sep<11>2014 17:40 Nov 12, 2024 Jkt 265001 required for publication. The National Science Advisory Board for Biosecurity meeting will include review of a new charge to the committee that, in keeping with the committee’s charter, is of vital importance to biomedical research, public health, and national security. If the meeting is not held on November 21, 2024, committee members and participants with the requisite scientific, technical, public health, biodefense, and national security expertise will be unable to participate due to scheduling conflicts. Information is also available on the Institute’s/Center’s home page: https://osp.od.nih.gov/policies/nationalscience-advisory-board-for-biosecuritynsabb#tab3/, where an agenda and any additional information for the meeting will be posted when available. Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E71, Rockville, MD 20892, 240–669–2915, samita.andreansky@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 6, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–26187 Filed 11–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Strategic Preparedness and Response [FR Doc. 2024–26268 Filed 11–12–24; 8:45 am] National Advisory Committee on Children and Disasters Public Meeting BILLING CODE 4140–01–P AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Research Committee (AIDS) Special Emphasis Panel. Date: December 5, 2024. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E71, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Samita S. Andreansky, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Frm 00082 Fmt 4703 Sfmt 4703 The National Advisory Committee on Children and Disasters (NACCD or the Committee) will conduct a public meeting (virtual) to discuss potential recommendations to the HHS Secretary and ASPR regarding challenges, opportunities, and priorities for national public health and medical preparedness, response, and recovery specific to the needs of children and their families in disasters. DATES: The public meeting (virtual) will be held December 4, 2024. ADDRESSES: A more detailed agenda and meeting registration link will be available on the NACCD meeting website at https://aspr.hhs.gov/ AboutASPR/WorkingwithASPR/ BoardsandCommittees/Pages/NACCD/ Public-Meetings.aspx. FOR FURTHER INFORMATION CONTACT: Zhoowan Jackson, NACCD Designated Federal Officer, Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS), Washington, DC; 202–205–4217, NACCD@hhs.gov. SUPPLEMENTARY INFORMATION: The NACCD is established by section 2811A of the Public Health Service Act (42 U.S.C. 300hh-10b) as amended by the Pandemic and All Hazards Preparedness and Advancing Innovation Act and governed by the provisions of the Federal Advisory Committee Act (5 U.S.C. app.). The statute directs the SUMMARY: National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting PO 00000 Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (HHS). ACTION: Notice. E:\FR\FM\13NON1.SGM 13NON1

Agencies

[Federal Register Volume 89, Number 219 (Wednesday, November 13, 2024)]
[Notices]
[Pages 89649-89650]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26198]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Charter Renewal for the Advisory Committee on Heritable Disorders 
in Newborns and Children

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that 
the Advisory Committee on Heritable Disorders in Newborns and Children 
(ACHDNC) charter has been renewed.

DATES: The effective date of charter renewal is November 10, 2024.

FOR FURTHER INFORMATION CONTACT: Leticia Manning, Maternal and Child 
Health Bureau, HRSA, 5600 Fishers Lane, 18N38A, Rockville, Maryland 
20857; 301-443-8335; or [email protected].

SUPPLEMENTARY INFORMATION: ACHDNC provides advice and recommendations 
to the Secretary of Health and Human Services (Secretary) on the 
development of newborn screening activities, technologies, policies, 
guidelines, and programs for effectively reducing morbidity and 
mortality in newborns and children having, or at risk for, heritable 
disorders. ACHDNC reviews and reports regularly on newborn and 
childhood screening practices, recommends improvements in the national 
newborn and childhood screening programs, and fulfills requirements 
stated in the authorizing legislation. In addition, ACHDNC's 
recommendations regarding inclusion of conditions for screening on the 
Recommended Uniform Screening Panel, following adoption by the 
Secretary, are evidence-informed preventive health services provided 
for in the comprehensive guidelines supported by HRSA pursuant to 
section 2713 of the Public Health Service Act (42 U.S.C. 300gg-13). 
Under this provision, non-grandfathered group health plans and health 
insurance issuers offering non-grandfathered group or individual health 
insurance are required to provide insurance coverage without cost-
sharing (a co-payment, co-insurance, or deductible) for preventive 
services for plan years (i.e., policy years) beginning on or after the 
date that is 1 year from the Secretary's adoption of the condition for 
screening.
    The charter renewal for the ACHDNC was approved on October 29, 
2024. The filing date is November 10, 2024. Renewal of the ACHDNC 
charter

[[Page 89650]]

authorizes the committee to operate until November 10, 2026
    A copy of the ACHDNC charter is available on the ACHDNC website at 
https://www.hrsa.gov/advisory-committees/heritable-disorders/. A copy of the charter also can be obtained by accessing the 
FACA database that is maintained by the Committee Management 
Secretariat under the General Services Administration. The website 
address for the FACA database is https://www.facadatabase.gov/.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-26198 Filed 11-12-24; 8:45 am]
BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.